Wells Fargo’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.46M Sell
102,980
-704
-0.7% -$16.8K ﹤0.01% 2771
2025
Q1
$2.58M Buy
103,684
+69,960
+207% +$1.74M ﹤0.01% 2628
2024
Q4
$635K Buy
33,724
+6,110
+22% +$115K ﹤0.01% 3565
2024
Q3
$416K Sell
27,614
-19,769
-42% -$298K ﹤0.01% 3747
2024
Q2
$1.36M Buy
47,383
+6,585
+16% +$188K ﹤0.01% 2983
2024
Q1
$1.19M Buy
40,798
+3,722
+10% +$109K ﹤0.01% 3024
2023
Q4
$1.25M Buy
37,076
+8,695
+31% +$293K ﹤0.01% 2965
2023
Q3
$871K Sell
28,381
-12,431
-30% -$381K ﹤0.01% 3170
2023
Q2
$1.64M Sell
40,812
-38,285
-48% -$1.53M ﹤0.01% 2910
2023
Q1
$3.23M Buy
79,097
+1,433
+2% +$58.5K ﹤0.01% 2312
2022
Q4
$3M Sell
77,664
-2,146
-3% -$82.9K ﹤0.01% 2327
2022
Q3
$4.25M Sell
79,810
-4,097
-5% -$218K ﹤0.01% 2020
2022
Q2
$4.89M Buy
83,907
+4,259
+5% +$248K ﹤0.01% 2021
2022
Q1
$6.08M Sell
79,648
-3,271
-4% -$250K ﹤0.01% 2160
2021
Q4
$4.99M Sell
82,919
-325,792
-80% -$19.6M ﹤0.01% 2438
2021
Q3
$22.9M Sell
408,711
-384,843
-48% -$21.6M 0.01% 1508
2021
Q2
$48.2M Sell
793,554
-774,020
-49% -$47M 0.01% 1062
2021
Q1
$110M Buy
1,567,574
+169,600
+12% +$11.9M 0.02% 604
2020
Q4
$83.7M Buy
1,397,974
+584,374
+72% +$35M 0.02% 716
2020
Q3
$48.9M Buy
813,600
+298,412
+58% +$17.9M 0.01% 878
2020
Q2
$27M Buy
515,188
+362,934
+238% +$19M 0.01% 1174
2020
Q1
$5.11M Buy
152,254
+19,771
+15% +$663K ﹤0.01% 2179
2019
Q4
$6M Sell
132,483
-15,458
-10% -$700K ﹤0.01% 2379
2019
Q3
$5.63M Sell
147,941
-10,269
-6% -$391K ﹤0.01% 2424
2019
Q2
$6.88M Buy
158,210
+26,438
+20% +$1.15M ﹤0.01% 2262
2019
Q1
$5.02M Buy
131,772
+55,133
+72% +$2.1M ﹤0.01% 2538
2018
Q4
$3.3M Buy
76,639
+6,305
+9% +$271K ﹤0.01% 2812
2018
Q3
$3.46M Buy
70,334
+817
+1% +$40.2K ﹤0.01% 2932
2018
Q2
$2.23M Sell
69,517
-96,156
-58% -$3.08M ﹤0.01% 3344
2018
Q1
$5.16M Buy
165,673
+28,314
+21% +$882K ﹤0.01% 2570
2017
Q4
$6.27M Buy
137,359
+15,774
+13% +$720K ﹤0.01% 2370
2017
Q3
$4.57M Buy
121,585
+38,940
+47% +$1.46M ﹤0.01% 2581
2017
Q2
$3.94M Sell
82,645
-5,013
-6% -$239K ﹤0.01% 2604
2017
Q1
$4M Buy
87,658
+37,407
+74% +$1.71M ﹤0.01% 2600
2016
Q4
$1.62M Buy
50,251
+11,299
+29% +$365K ﹤0.01% 3270
2016
Q3
$1.33M Sell
38,952
-316,298
-89% -$10.8M ﹤0.01% 3223
2016
Q2
$12M Sell
355,250
-212,881
-37% -$7.18M ﹤0.01% 1681
2016
Q1
$30.1M Buy
568,131
+244,719
+76% +$13M 0.01% 1037
2015
Q4
$24.8M Buy
323,412
+280,924
+661% +$21.6M 0.01% 1172
2015
Q3
$1.75M Sell
42,488
-459,270
-92% -$18.9M ﹤0.01% 3041
2015
Q2
$35.5M Sell
501,758
-165,448
-25% -$11.7M 0.01% 989
2015
Q1
$59.3M Buy
667,206
+208,919
+46% +$18.6M 0.02% 711
2014
Q4
$40.6M Buy
458,287
+51,223
+13% +$4.54M 0.02% 874
2014
Q3
$39.5M Buy
407,064
+2,279
+0.6% +$221K 0.02% 858
2014
Q2
$37.2M Buy
404,785
+240,616
+147% +$22.1M 0.02% 927
2014
Q1
$11.5M Buy
164,169
+37,962
+30% +$2.66M ﹤0.01% 1683
2013
Q4
$7.26M Buy
126,207
+7,290
+6% +$419K ﹤0.01% 1973
2013
Q3
$5.72M Buy
118,917
+12,307
+12% +$592K ﹤0.01% 2094
2013
Q2
$3.09M Buy
+106,610
New +$3.09M ﹤0.01% 2475